6.
Tu C, Rudnick P, Martinez M, Cheek K, Stein S, Slebos R
. Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res. 2010; 9(10):4982-91.
PMC: 2948641.
DOI: 10.1021/pr100646w.
View
7.
Qian W, Kaleta D, Petritis B, Jiang H, Liu T, Zhang X
. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics. 2008; 7(10):1963-73.
PMC: 2559934.
DOI: 10.1074/mcp.M800008-MCP200.
View
8.
Barnidge D, Dasari S, Botz C, Murray D, Snyder M, Katzmann J
. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res. 2014; 13(3):1419-27.
DOI: 10.1021/pr400985k.
View
9.
Sweet S, Chain D, Yu W, Martin P, Rebelatto M, Chambers A
. The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies. Sci Rep. 2022; 12(1):13876.
PMC: 9381555.
DOI: 10.1038/s41598-022-16358-1.
View
10.
Nanjappa V, Thomas J, Marimuthu A, Muthusamy B, Radhakrishnan A, Sharma R
. Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res. 2013; 42(Database issue):D959-65.
PMC: 3965042.
DOI: 10.1093/nar/gkt1251.
View
11.
Hebert A, Prasad S, Belford M, Bailey D, McAlister G, Abbatiello S
. Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer. Anal Chem. 2018; 90(15):9529-9537.
PMC: 6145172.
DOI: 10.1021/acs.analchem.8b02233.
View
12.
Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M
. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma. N Engl J Med. 2017; 376(14):1311-1320.
PMC: 6201242.
DOI: 10.1056/NEJMoa1611750.
View
13.
Guthals A, Gan Y, Murray L, Chen Y, Stinson J, Nakamura G
. De Novo MS/MS Sequencing of Native Human Antibodies. J Proteome Res. 2016; 16(1):45-54.
PMC: 5574256.
DOI: 10.1021/acs.jproteome.6b00608.
View
14.
Bondt A, Hoek M, Tamara S, de Graaf B, Peng W, Schulte D
. Human plasma IgG1 repertoires are simple, unique, and dynamic. Cell Syst. 2021; 12(12):1131-1143.e5.
PMC: 8691384.
DOI: 10.1016/j.cels.2021.08.008.
View
15.
Zhu W, Smith J, Huang C
. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol. 2009; 2010:840518.
PMC: 2775274.
DOI: 10.1155/2010/840518.
View
16.
Zajec M, Jacobs J, de Kat Angelino C, Dekker L, Stingl C, Luider T
. Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and Quantification. J Proteome Res. 2020; 19(7):2845-2853.
DOI: 10.1021/acs.jproteome.9b00705.
View
17.
Lee J, Paparoditis P, Horton A, Fruhwirth A, McDaniel J, Jung J
. Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. Cell Host Microbe. 2019; 25(3):367-376.e5.
PMC: 6417944.
DOI: 10.1016/j.chom.2019.01.010.
View
18.
Klaassen T, Szwandt S, Kapron J, Roemer A
. Validated quantitation method for a peptide in rat serum using liquid chromatography/high-field asymmetric waveform ion mobility spectrometry. Rapid Commun Mass Spectrom. 2009; 23(15):2301-6.
DOI: 10.1002/rcm.4147.
View
19.
Muth T, Renard B
. Evaluating de novo sequencing in proteomics: already an accurate alternative to database-driven peptide identification?. Brief Bioinform. 2017; 19(5):954-970.
DOI: 10.1093/bib/bbx033.
View
20.
Kulak N, Geyer P, Mann M
. Loss-less Nano-fractionator for High Sensitivity, High Coverage Proteomics. Mol Cell Proteomics. 2017; 16(4):694-705.
PMC: 5383787.
DOI: 10.1074/mcp.O116.065136.
View